Pennsylvania’s attorney general accuses insulin makers, PBMs of insulin ‘pricing scheme’
State Attorney General Dave Sunday’s office claims that more than a dozen pharmaceutical companies and pharmacy middlemen worked together to “artificially” inflate insulin prices by more than 1,000%. “Millions of Pennsylvanians have diabetes or prediabetes and they were all potentially harmed by this scheme to artificially inflate pricing to maximize company profits,” Sunday said in […]
Original Source
Read the full article at Penncapital-star →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.